Insulin Degludec and Insulin Aspart Injection

诺和诺德（中国）制药有限公司🇨🇳 National Medical Products Administration

Approval Id: 8FECI98q0Wx
Approval Number: 国药准字S20227005
Generic Name: 德谷门冬双胰岛素注射液
Generic Name En: Insulin Degludec and Insulin Aspart Injection
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 3ml:300单位(笔芯)
Reg Date: 2022-03-31
Company Name: 诺和诺德（中国）制药有限公司
Company Address: 天津经济技术开发区南海路
Production Company Name: 诺和诺德（中国）制药有限公司
Production Company Address: 天津经济技术开发区南海路99号
Company Detail Path: /organization/nuo-he-nuo-de-zhong-guo-zhi-yao-you-xian-gong-si
Production Company Detail Path: /organization/nuo-he-nuo-de-zhong-guo-zhi-yao-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Mar 31, 2022

Approval ID

8FECI98q0Wx

Type

生物制品